Synopsis
Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. By 1023
2. By-1023
3. By1023
4. Pantoprazole
5. Protonix
6. Sk And F 96022
7. Sk And F-96022
8. Sk And F96022
9. Skf 96022
10. Skf-96022
11. Skf96022
1. 138786-67-1
2. Pantoloc
3. Protonix
4. Pantecta
5. Zurcal
6. Pantoprazole Sodium Salt
7. Skf96022 Sodium
8. By-1023 Sodium
9. Chebi:50270
10. Sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
11. Pantozol Control
12. 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl) Sulfinyl)-1h-benzimidazole Sodium
13. Dsstox_cid_24215
14. Dsstox_rid_80123
15. Dsstox_gsid_44215
16. Sodium 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
17. Sodium 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide
18. Cas-138786-67-1
19. Anagastra
20. Inipomp
21. Pantorc
22. Peptazol
23. Ulcotenal
24. Citrel
25. Apton
26. Rifun
27. Pantoprazole Sodium;
28. By1023 (sodium)
29. Pantoprazole Sodium,(s)
30. Skf96022 (sodium)
31. Schembl3543
32. Mls001424073
33. Pantoprazole Sodium Monohydrate
34. Chembl1200408
35. Dtxsid7044215
36. Dz-2352a
37. Hms2051l19
38. Hms3393l19
39. Hms3715d12
40. Act02633
41. Tox21_112996
42. Tox21_302362
43. Mfcd01658543
44. S4538
45. Akos015994677
46. Ccg-100980
47. Ks-1093
48. Nc00230
49. S86p671
50. Sb17369
51. By-1023/sk&f-96022
52. Ncgc00255835-01
53. Smr000469592
54. Ft-0602602
55. Ft-0673508
56. A807440
57. B-8610-23/sk&f-96022-z
58. J-516336
59. B-8510-29
60. Q27122012
61. Sodium 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl] Benzimidazol-1-ide
62. 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1h-benzo[d]imidazole, Sodium Salt
63. 5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-ide; Sodium;pantoprazole Sodium
64. Sodium 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole
65. Sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide
1. Pantozol
2. S-pantoprazole
3. Pantoprazole
| Molecular Weight | 405.4 g/mol |
|---|---|
| Molecular Formula | C16H14F2N3NaO4S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 405.05707772 g/mol |
| Monoisotopic Mass | 405.05707772 g/mol |
| Topological Polar Surface Area | 90.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 497 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Pantoprazole sodium |
| Drug Label | The active ingredient in pantoprazole sodium delayed-release tablets USP is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid... |
| Active Ingredient | Pantoprazole sodium |
| Dosage Form | Injectable; Tablet, delayed release |
| Route | injection; Iv (infusion); Oral |
| Strength | eq 20mg base; eq 40mg base/vial; eq 40mg base; 40mg |
| Market Status | Tentative Approval; Prescription |
| Company | Wockhardt; Mylan Pharms; Hetero Labs Ltd V; Teva Parenteral; Teva; Apotex; Aurobindo Pharma; Torrent Pharms; Sun Pharma Global; Perrigo R And D; Actavis Elizabeth; Macleods Pharms; Jubilant Generics; Kudco Ireland; Ranbaxy Labs; Dr Reddys Labs; Akorn |
| 2 of 4 | |
|---|---|
| Drug Name | Protonix iv |
| Active Ingredient | Pantoprazole sodium |
| Dosage Form | Injectable |
| Route | Iv (infusion) |
| Strength | eq 40mg base/vial |
| Market Status | Prescription |
| Company | Wyeth Pharms |
| 3 of 4 | |
|---|---|
| Drug Name | Pantoprazole sodium |
| Drug Label | The active ingredient in pantoprazole sodium delayed-release tablets USP is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid... |
| Active Ingredient | Pantoprazole sodium |
| Dosage Form | Injectable; Tablet, delayed release |
| Route | injection; Iv (infusion); Oral |
| Strength | eq 20mg base; eq 40mg base/vial; eq 40mg base; 40mg |
| Market Status | Tentative Approval; Prescription |
| Company | Wockhardt; Mylan Pharms; Hetero Labs Ltd V; Teva Parenteral; Teva; Apotex; Aurobindo Pharma; Torrent Pharms; Sun Pharma Global; Perrigo R And D; Actavis Elizabeth; Macleods Pharms; Jubilant Generics; Kudco Ireland; Ranbaxy Labs; Dr Reddys Labs; Akorn |
| 4 of 4 | |
|---|---|
| Drug Name | Protonix iv |
| Active Ingredient | Pantoprazole sodium |
| Dosage Form | Injectable |
| Route | Iv (infusion) |
| Strength | eq 40mg base/vial |
| Market Status | Prescription |
| Company | Wyeth Pharms |
Short-term treatment of reflux symptoms (e. g. heartburn, acid regurgitation) in adults.
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
A02BC02
API SUPPLIERS
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36375
Submission : 2021-12-28
Status : Active
Type : II
Certificate Number : CEP 2024-140 - Rev 00
Issue Date : 2024-06-10
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2025-02-27
Valid Till : 2028-03-17
Written Confirmation Number : WC-0004
Address of the Firm :
NDC Package Code : 49716-334
Start Marketing Date : 2023-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : RU |
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Certificate Number : CEP 2023-421 - Rev 00
Issue Date : 2024-07-16
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2024-08-16
Valid Till : 2027-02-26
Written Confirmation Number : WC-0494
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35577
Submission : 2021-03-29
Status : Active
Type : II
Certificate Number : CEP 2021-168 - Rev 01
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm :
NDC Package Code : 42765-001
Start Marketing Date : 2018-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-02-07
Pay. Date : 2019-02-01
DMF Number : 17103
Submission : 2004-01-20
Status : Active
Type : II
Certificate Number : R1-CEP 2010-319 - Rev 01
Issue Date : 2017-03-28
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2022-05-26
Valid Till : 2025-06-25
Written Confirmation Number : WC-0035
Address of the Firm :
NDC Package Code : 55111-051
Start Marketing Date : 2004-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Jai Radhe Sales is your partner for all your sourcing needs.
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-22
Pay. Date : 2019-03-11
DMF Number : 18779
Submission : 2005-09-15
Status : Active
Type : II
Certificate Number : R1-CEP 2009-323 - Rev 02
Issue Date : 2020-01-31
Type : Chemical
Substance Number : 2296
Status : Valid
NDC Package Code : 68069-0005
Start Marketing Date : 2010-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : ASMF |
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36375
Submission : 2021-12-28
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35577
Submission : 2021-03-29
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-27
Pay. Date : 2020-03-23
DMF Number : 24813
Submission : 2011-03-31
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2019-02-07
Pay. Date : 2019-02-01
DMF Number : 17103
Submission : 2004-01-20
Status : Active
Type : II
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-22
Pay. Date : 2019-03-11
DMF Number : 18779
Submission : 2005-09-15
Status : Active
Type : II
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15886
Submission : 2002-02-28
Status : Active
Type : II
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Complete
Rev. Date : 2023-05-04
Pay. Date : 2023-04-18
DMF Number : 36849
Submission : 2022-05-19
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19917
Submission : 2006-10-30
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-13
DMF Number : 17118
Submission : 2004-01-26
Status : Active
Type : II
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36393
Submission : 2021-10-18
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
Pantoprazole Sodium Sesquihydrate, Process-II
Certificate Number : CEP 2024-140 - Rev 00
Status : Valid
Issue Date : 2024-06-10
Type : Chemical
Substance Number : 2296
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
Pantoprazole Sodium Sesquihydrate
Certificate Number : R0-CEP 2021-427 - Rev 00
Status : Valid
Issue Date : 2022-11-02
Type : Chemical
Substance Number : 2296
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2023-421 - Rev 00
Status : Valid
Issue Date : 2024-07-16
Type : Chemical
Substance Number : 2296
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Pantoprazole Sodium Sesquihydrate, PAS Process
Certificate Number : CEP 2023-127 - Rev 01
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2021-168 - Rev 01
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Pantoprazole Sodium Sesquihydrate
Certificate Number : R1-CEP 2010-319 - Rev 01
Status : Valid
Issue Date : 2017-03-28
Type : Chemical
Substance Number : 2296
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
Pantoprazole Sodium Sesquihydrate
Certificate Number : R1-CEP 2009-323 - Rev 02
Status : Valid
Issue Date : 2020-01-31
Type : Chemical
Substance Number : 2296
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2008-065 - Rev 03
Status : Valid
Issue Date : 2024-09-02
Type : Chemical
Substance Number : 2296
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Pantoprazole Sodium Sesquihydrate, Form-I
Certificate Number : CEP 2022-383 - Rev 00
Status : Valid
Issue Date : 2024-08-07
Type : Chemical
Substance Number : 2296
Pantoprazole Sodium Sesquihydrate
Certificate Number : R0-CEP 2009-046 - Rev 00
Status : Expired
Issue Date : 2010-07-21
Type : Chemical
Substance Number : 2296
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - POWDER;INTRAVENOUS - EQ 40MG BASE/VI...DOSAGE - POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL
USFDA APPLICATION NUMBER - 209463
DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20...DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE
USFDA APPLICATION NUMBER - 20987
DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 40...DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE
USFDA APPLICATION NUMBER - 20987
DOSAGE - INJECTABLE;INTRAVENOUS - EQ 40MG BAS...DOSAGE - INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL
USFDA APPLICATION NUMBER - 20988
Related Excipient Companies
Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Minbiotech
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Avesta Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Direct Compression
Disintegrants & Superdisintegrants
Solubilizers
Taste Masking
Thickeners and Stabilizers
Granulation
Film Formers & Plasticizers
Co-Processed Excipients
Lubricants & Glidants
Topical
Chewable & Orodispersible Aids
Parenteral
Emulsifying Agents
Surfactant & Foaming Agents
API Stability Enhancers
Rheology Modifiers
Empty Capsules
Coloring Agents
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
Patent Expiration Date : 2025-03-30
US Patent Number : 7838027*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2025-03-30
US Patent Number : 7553498*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2025-03-30
US Patent Number : 7550153*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2026-12-07
US Patent Number : 7544370*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-07
Patent Expiration Date : 2026-06-07
US Patent Number : 7544370
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-06-07
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]US Exclusivities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Health Canada Patents
Patent Expiration Date : 2021-11-17
Date Granted : 2006-05-23
Brand Name : PANTO IV
Patent Number : 2428870
Filing Date : 2001-11-17
Strength per Unit : 40mg
Dosage Form : Lyophilized Powder
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-11-17
Date Granted : 2006-05-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTO-BYK
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTOLOC
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTOLOC
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTO-BYK
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTO-BYK
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Brand Name : PANTO-BYK
Patent Number : 2109697
Filing Date : 1992-06-13
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTOLOC
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Brand Name : PANTOLOC
Patent Number : 2109697
Filing Date : 1992-06-13
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTOLOC
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
84
PharmaCompass offers a list of Pantoprazole Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pantoprazole Sodium manufacturer or Pantoprazole Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pantoprazole Sodium manufacturer or Pantoprazole Sodium supplier.
PharmaCompass also assists you with knowing the Pantoprazole Sodium API Price utilized in the formulation of products. Pantoprazole Sodium API Price is not always fixed or binding as the Pantoprazole Sodium Price is obtained through a variety of data sources. The Pantoprazole Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ulcotenal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ulcotenal, including repackagers and relabelers. The FDA regulates Ulcotenal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ulcotenal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ulcotenal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ulcotenal supplier is an individual or a company that provides Ulcotenal active pharmaceutical ingredient (API) or Ulcotenal finished formulations upon request. The Ulcotenal suppliers may include Ulcotenal API manufacturers, exporters, distributors and traders.
click here to find a list of Ulcotenal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ulcotenal DMF (Drug Master File) is a document detailing the whole manufacturing process of Ulcotenal active pharmaceutical ingredient (API) in detail. Different forms of Ulcotenal DMFs exist exist since differing nations have different regulations, such as Ulcotenal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ulcotenal DMF submitted to regulatory agencies in the US is known as a USDMF. Ulcotenal USDMF includes data on Ulcotenal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ulcotenal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ulcotenal suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ulcotenal Drug Master File in Korea (Ulcotenal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ulcotenal. The MFDS reviews the Ulcotenal KDMF as part of the drug registration process and uses the information provided in the Ulcotenal KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ulcotenal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ulcotenal API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ulcotenal suppliers with KDMF on PharmaCompass.
A Ulcotenal CEP of the European Pharmacopoeia monograph is often referred to as a Ulcotenal Certificate of Suitability (COS). The purpose of a Ulcotenal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ulcotenal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ulcotenal to their clients by showing that a Ulcotenal CEP has been issued for it. The manufacturer submits a Ulcotenal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ulcotenal CEP holder for the record. Additionally, the data presented in the Ulcotenal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ulcotenal DMF.
A Ulcotenal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ulcotenal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ulcotenal suppliers with CEP (COS) on PharmaCompass.
A Ulcotenal written confirmation (Ulcotenal WC) is an official document issued by a regulatory agency to a Ulcotenal manufacturer, verifying that the manufacturing facility of a Ulcotenal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ulcotenal APIs or Ulcotenal finished pharmaceutical products to another nation, regulatory agencies frequently require a Ulcotenal WC (written confirmation) as part of the regulatory process.
click here to find a list of Ulcotenal suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ulcotenal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ulcotenal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ulcotenal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ulcotenal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ulcotenal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ulcotenal suppliers with NDC on PharmaCompass.
Ulcotenal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ulcotenal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ulcotenal GMP manufacturer or Ulcotenal GMP API supplier for your needs.
A Ulcotenal CoA (Certificate of Analysis) is a formal document that attests to Ulcotenal's compliance with Ulcotenal specifications and serves as a tool for batch-level quality control.
Ulcotenal CoA mostly includes findings from lab analyses of a specific batch. For each Ulcotenal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ulcotenal may be tested according to a variety of international standards, such as European Pharmacopoeia (Ulcotenal EP), Ulcotenal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ulcotenal USP).
